Evidence map›Paper›PMID 38151833›Full record

ArticleCurrent drug discovery technologies2024

Biological Activities of Zinc Oxide Nanoparticles Green Synthesized Using the Aqueous Extract of

Foroogh Mirzania, Iraj Salimikia, Javad Ghasemian Yadegari, Abdolrazagh Marzban, Amirmasoud Firouzi, Alireza Nazarzadeh, Javid Aalaei

Abstract read
PubMed Publisher
In one paragraph

Article in Current drug discovery technologies, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Foroogh MirzaniaRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.ORCID 0000-0003-4072-4233
Iraj SalimikiaDepartment of Pharmacognosy, Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, 381351698, Lorestan Province, Iran.
Javad Ghasemian YadegariDepartment of Pharmacognosy, Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, 381351698, Lorestan Province, Iran.
Abdolrazagh MarzbanRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Amirmasoud FirouziStudent Research Committee, Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran.
Alireza NazarzadehStudent Research Committee, Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran.
Javid AalaeiStudent Research Committee, Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

objectiveIn this study, aqueous extract of

methodsTo confirm nanoparticles synthesis, SEM, TEM, UV-Vis, FTIR, and XRD were used. The synthesized ZnO-NPs were studied for antimicrobial activities by microdilution method for calculating MIC and MBC. Analysis of ZnO-NPs confirmed successful synthesis by extract of D. kotschyi.

resultsThe sizes of ZnO-NPs were estimated 50-200 nm in diameter. Antibacterial and antifungal experiments showed potent activities against

conclusionThe noteworthy point is that the inhibitory rate of synthesized zinc oxide nanoparticles is higher compared to broad-spectrum antibiotics, such as chloramphenicol (MIC values 15 mg/ml). Determining the therapeutic and toxic dose of this product for humans requires further investigation and clinical trials.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsCandida albicansGreen Chemistry TechnologyMicrobial Sensitivity TestsPlant ExtractsZinc OxideAnti-Infective AgentsLamiaceaeMetal NanoparticlesNanoparticlesPseudomonas aeruginosaStaphylococcus aureusAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsPlant ExtractsZinc Oxideantimicrobial propertiesDeracocephalum kotschyi Boissgreen synthesisPseudomonas aeruginosa.Staphylococos aureusZinc oxide nanoparticles

Identifiers

PMID38151833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.